K
KONIKU
Is a wetware company specialising in neuron electronic interfacing
About KONIKU
Koniku is a synthetic biotechnology startup that merges biology with technology to create 'smell cyborgs', devices capable of detecting and analyzing volatile organic compounds in the air. These devices, which combine live cells with silicon, are designed to function as sensors, amplifiers, and biological signal processors. The company's ultimate goal is to place these devices in 10 million homes within the decade, with the aim of diagnosing diseases and maintaining health in real-time.
Read full description
Koniku's business model revolves around creating a marketplace for individual health management. By providing real-time health data, they empower individuals to take charge of their own health. The company operates in the biotechnology and health tech markets, serving clients ranging from individual consumers to Fortune 500 companies.
The company generates revenue by selling their 'smell cyborgs' and through their Koniku Technology Integrator Ecosystem (KTIE). The KTIE is a community of solutions developers, fostering businesses from startups to large corporations. This ecosystem allows for the integration of Koniku's technology into various applications, creating additional revenue streams.
Koniku's unique approach to health tech involves feeding the data collected by their devices into a machine learning backend. This allows the company to classify and create value from all smells that impact human life, creating a proprietary data set that can be leveraged for various applications.
At a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- San Rafael, United States
- Employees
- 5
- Open positions
- None listed
- Dealroom signal
- 66.9/100
- Industry
- Health, Security
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Visualization, Biotechnology, Neurology, Synthetic Biology
- Technology
- Deep Tech, Recognition Technology, IoT InternetOfThings
- Business model
- Manufacturing
- Client focus
- b2b, b2c
Latest news
Press, funding announcements and product moves mentioning KONIKU.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Dec 2021 | $48M | $350M | SOSV · Evolution VC Partners · Platform Capital Investment Partners · Indie Bio | ↗ |
| CONVERTIBLEOther financing | Jan 2021 | $11M | — | Airbus Ventures | — |
Growth signals
Latest recorded traffic for KONIKU is 2.2K monthly website visits, up 228.4% over the last three months. KONIKU's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
SOSV
Mission and Market
Half Court VC
Series A6 investors entered at this stage
Airbus Ventures- PPPlatform Capital Investment Partners
Evolution VC Partners
Indie Bio
IDO Investments
Oriza Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about KONIKU on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See KONIKU’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.